Press Release

Aug, 23 2022

GlaxoSmithKline Plc, Bayer AG, and Reckitt Benckiser Group PLC are Dominating the Europe Effervescent Tablet Market in 2020

Europe Effervescent Tablet Market is expected to grow with a CAGR of 7.6% in the forecast period of 2021 to 2028. The years considered for the study are as mentioned below.

Access Full Report @

Europe effervescent tablet market is a highly consolidated market, which includes a specific number of key players. The market has witnessed increased strategic developments owing to favorable market scenarios.

The major players dealing in Europe effervescent tablet market are introducing a strong range of products provider along with launching new products and adopting strategic initiatives such as acquisition, agreement, business expansion, award, and recognition into the market. This helped companies to maximize sales with an enhanced product portfolio.

For instance:

  • In March 2021, SCITECH has recently introduced the world’s smallest effervescent tablet Minifiz Efftab 140. This would be the smallest effervescent tablet providing the same effect for meeting Vitamin D 3 needs. This has expanded their product portfolio.

Reckitt Benckiser Group PLC company is the dominating player in Europe effervescent tablet market. The other key players existing in the market are Reckitt Benckiser Group PLC, Bayer AG, CHIESI SAS, HERMES ARZNEIMITTEL, Perrigo Company plc, Dietpharm, Bliss GVS Pharma Limited, SCITECH, Alpex, Herbalife International of America, Inc, Natur Produkt Zdrovit Sp Z O O, and Vitabiotics Ltd

Europe Effervescent Tablet MarketReckitt Benckiser Group PLC.

 Reckitt Benckiser Group PLC, founded in the year 1819, is headquartered in Berkshire, USA. The company focuses to protect, heal and nurture the world by providing innovative hygiene, health, nutrition products, and services.  The company is exclusively focusing on different brands such as Clearasil, Enfa, Finish, Lysol, Veet, Dettol, Durex, Calgon, Cillit, Nurofen, Nutramigen, Scholl, Stepshil, Venish, Harpic, Woolite, Airborne, Move Free, and Neuriva, among others. The company operates its business via several business segments, including hygiene, health, and nutrition, in which nutrition is the market-focused segment.

For instance,

  • In February 2021, Reckitt Benckiser Group PLC announces that they are partnering with the British Red Cross in its efforts to make vulnerable communities strong and resilient. This will enhance their image and customers value

The company has a presence across Europe, Asia-Pacific, Middle East, and Africa, South America, and North America. The company also has various subsidiaries, including R.B. Holding Europe Du Sud SAS (France), R.B. Hygiene Home France SAS (France) ORD (France), Reckitt Benckiser Chartres SAS (France), Reckitt Benckiser France SAS ORD (France), Reckitt Benckiser Healthcare France SAS (France) and others.

GlaxoSmithKline plc

GlaxoSmithKline plc was founded in the year 1715. GlaxoSmithKline plc is headquartered in the  United Kindom. The company focuses on millions of people and customers by providing and developing innovative medicine, vaccine, and consumer healthcare products. The company serves in various product categories, including pharmaceuticals, vaccines, and consumer healthcare, where healthcare is the market-focused category.

For instance,

  • In July, GlaxoSmithKline plc announces to enhance the efficiency and competitiveness of their manufacturing network. These include both investments for respiratory and HIV medicines manufacturing in the U.K. This has provided company strategic ideas to increase sales and revenue of consumer healthcare products

The company has a wide presence across the south and Central America, Asia, Middle East, and Africa, Europe, and others. The company also has various subsidiary companies Domantis ltd. (U.K.), Glaxo welcome U.K. ltd (U.K.)


Bayer AG was founded in the year 1863, headquartered in Leverkusen, Germany. The company focuses on life science and provides in the areas of healthcare and agriculture with their innovative products and solutions. The company operates its business via several business segments, including corp science, pharmaceuticals, and consumer health, in which consumer health is the market-focused segment.

For instance,

  • In February 2021, Bayer AG announced to launch their new initiative, which is “The Nutrient Gap Initiative,” to expands the access of vitamins and minerals for underserved communities to help combat malnutrition. This will enable the company to raise future sales.

The company has a presence across Latin America, Asia Pacific, North America, Europe, and the Middle East, and Africa. The company also has various subsidiaries, including Bayer (Proprietary) Limited (South Africa), Bayer (Schweiz) A.G. ( Switzerland), Bayer A/S (Denmark), Bayer AB (Sweden), Bayer Agriculture Limited (U.K.), among others.

Client Testimonials